RAD51 and breast cancer: For the main subtypes of breast cancer, expression of RAD51 was increasing, in ascending order, in luminal (n = 566), Her2-positive (n = 37) and triple-negative breast cancer tissues (n = 116) compared with normal tissues (n = 114) (all P < 0.05) (Fig. 5C).